Irminix (OSR1) Phase 2a Clinical Trials Report
EmeraMed Limited Company completed the clinical portion of its Phase 2a pilot trial for Irminix (the new name of OSR1 product). The trial was reported on 36 mercury intoxicated gold…
EmeraMed Limited Company completed the clinical portion of its Phase 2a pilot trial for Irminix (the new name of OSR1 product). The trial was reported on 36 mercury intoxicated gold…
Many of you have been following the redevelopment and reintroduction of the powerful and effective OSR#1 supplement that we used to recommend for metal chelation and as a antioxidant. The…
NBMI, what used to be called OSR#1, starts the next step for approval to come back on the market. NBMI was approved by the Ministry of Health in Ecuador for…
CTI Science has completed all pre-clinical work on OSR I (now known as NBMI) and submitted the application to the Swedish Medicinal Products Agency (MPA) to conduct the Phase I…